Re: What if
in response to
by
posted on
Mar 07, 2019 09:33AM
"I'd like to hear from Bear on the accuracy of this statement. 'RVX did find plaque regression in a big way in the RVX-208 + rosuvastatin cohort of the trial'"
I just responded to Fouremm on this topic. I recommend you take a long, hard look at the plaque regression data in the patent. More complex than just statin type. See here:
https://agoracom.com/ir/Resverlogix/forums/discussion/topics/723759-what-if/messages/2224388#message
BearDownAZ